Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $3.00 by Analysts at Cantor Fitzgerald

Retrieved on: 2022-05-11 13:22:23

Tags for this article:

Financial markets

Finance

Financial economics

Medical research

Inovio Pharmaceuticals

Price?earnings ratio

Stock

Short

Inovio COVID-19 vaccine

INOVIO PHARMACEUTICALS , INC

Click the tags to see associated articles and topics

Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $3.00 by Analysts at Cantor Fitzgerald. View article details on hiswai:

Excerpt

WINTON GROUP Ltd now owns 31,567 shares of the biopharmaceutical company's stock valued at $158,000 after purchasing an additional 3,519 shares during ...

Article found on: www.defenseworld.net

View Original Article